drugset
drugset / Trial / NCT00160420

A Long-Term Study to Evaluate the Safety of Asoprisnil in the Treatment of Women With Endometriosis From Study M01-398

NCT00160420 ↗

Phase 2 Completed 73 enrolled Abbott
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The objective of this study is to determine the long-term safety of asoprisnil 5 mg for 12 months in women with endometriosis from study M01-398.

Timeline

Start
2002-12
Primary completion
2004-07
Completion
2004-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Asoprisnil Other / unclassified 5 mg Oral

Indications

endometriosis